Infinimmune Pipeline
| Drug | Indication | Phase |
|---|
| IFX-101 | Moderate-to-Severe Atopic Dermatitis (msAD) | Preclinical |
| IFX-201 | Moderate-to-Severe Atopic Dermatitis (msAD) | Preclinical |
| IFX-301 | IgA Nephropathy (IgAN) | Preclinical |
| IFX-401 | Ulcerative Colitis (UC) | Preclinical |
| IFX-501 | Undisclosed | Undisclosed |
| Immunome Partnership | Undisclosed | Undisclosed |